TREATMENT FOR INTERSTITIAL LUNG DISEASE
Application
US20260076929A1
Kind: A1
Mar 19, 2026
Assignee
United Therapeutics Corporation
Inventors
Leigh Peterson, Peter Smith, Chunqin Deng
Abstract
Methods of treating of interstitial lung disease, reducing pulmonary function decline in a subject with interstitial lung disease (ILD), and increasing forced vital capacity (FVC) in a subject suffering from ILD are provided, wherein the methods include administration of treprostinil.
CPC Classifications
A61K 31/192
A61K 9/0075
A61K 9/0078
A61P 9/12
Filing Date
2025-11-25
Application No.
19400227